Scientists hope they are closer to a cure for HIV after eliminating virus from cells using gene-editing tool

Nina Massey
Press Association
2 Min Read
The researchers are looking for a way to target HIV wherever it appears in the body.
The researchers are looking for a way to target HIV wherever it appears in the body. Credit: WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH/AAP

Researchers have eliminated HIV from cells in a laboratory, raising hopes of a cure.

Using a gene-editing tool known as CRISPR-Cas, which won the Nobel Prize in 2020, scientists were able target HIV DNA, removing all traces of the virus from infected cells.

Working in essence as scissors, the technology can cut the DNA at certain points, allowing unwanted genes to be deleted or new genetic material to be introduced into cells.

Sign up to The Nightly's newsletters.

Get the first look at the digital newspaper, curated daily stories and breaking headlines delivered to your inbox.

Email Us
By continuing you agree to our Terms and Privacy Policy.

The study authors said their aim was to develop a robust and safe CRISPR-Cas regimen, “striving for an inclusive ‘HIV cure for all’ that can inactivate diverse HIV strains across various cellular contexts”.

The scientists, led by Dr Elena Herrera-Carrillo and part of her team (Yuanling Bao, Zhenghao Yu and Pascal Kroon) at Amsterdam UMC, the Netherlands, said they had developed an efficient attack on the virus in various cells and where it might be hiding.

“These findings represent a pivotal advancement towards designing a cure strategy,” they said.

HIV can infect different types of cells and tissues in the body, so the researchers are looking for a way to target the virus wherever it appears.

In the new study, presented at the European Congress of Clinical Microbiology and Infectious Diseases, the researchers focused on parts of the virus that stay the same across all known HIV strains.

They said the approach aimed to provide a broad-spectrum therapy capable of combating multiple HIV variants effectively.

According to the researchers, their work represents proof of concept, and will not become a cure for HIV tomorrow.

The next steps involve optimising the delivery route to target the majority of the HIV reservoir cells.

The hope is to devise a strategy to make this system as safe as possible for future clinical applications and achieve the right balance between efficacy and safety.

“Only then can we consider clinical trials of ‘cure’ in humans to disable the HIV reservoir,” the researchers said.

“While these preliminary findings are very encouraging, it is premature to declare that there is a functional HIV cure on the horizon.”

Latest Edition

The front page of The Nightly for 17-05-2024

Latest Edition

Edition Edition 17 May 202417 May 2024

Shadowy South American crime figure at centre of alleged gambling scandal that’s rocked Aussie sport.